A real‐world, observational study of erenumab for migraine prevention in Canadian patients - Becker, Werner J.; Spacey, Sian; Leroux, Elizabeth; Giammarco, Rose; Gladstone, Jonathan; Christie, Suzanne; Akaberi, Arash; Power, G. Sarah; Minhas, Jagdeep K.; Mancini, Johanna; Rochdi, Driss; Filiz, Ayca; et al. (Headache, 2022)
Keywords: Adult; Analgesics - therapeutic use; Antibodies, Monoclonal, Humanized; Calcitonin Gene-Related Peptide Receptor Antagonists; Canada; chronic migraine; Clinical trials; Double-Blind Method; effectiveness; episodic migraine; erenumab; Headache; Health services; Humans; Migraine; Migraine Disorders - chemically induced; Migraine Disorders - drug therapy; Migraine Disorders - prevention & control; Monoclonal antibodies; Observational studies; Patients; Physicians; Prevention; Prospective Studies; Questionnaires; real‐world; Reduction; Research Submissions; Safety; Treatment Outcome; Canada; effectiveness; real-world; episodic migraine; erenumab; chronic migraine